The Drug Enforcement Administration has issued its first federal registrations to state-licensed medical cannabis businesses under Schedule III, and has given registrants until Nov. 29, 2026 to cut ties with businesses that are not part of the federal system, Cannabis Business Times reported.
The first round
On Oct. 30, the U.S. Department of Justice announced that the DEA had issued more than 900 dispensary registrations across seven states: Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia. All seven have medical-only programs.
The approvals came from an expedited process that followed Attorney General Todd Blanche’s April 23, 2026 order moving state-licensed medical marijuana to Schedule III. Nearly 7,000 businesses applied during the 60-day window that closed June 26: 4,197 dispensaries, 2,086 manufacturers and 710 distributors.
The DOJ said reviews of manufacturers and distributors need more work, including facility inspections, production controls and quota decisions, so dispensaries are being handled first.
The Nov. 29 rule
Under the new DOJ guidance, “timely applicants” and registrants may do Schedule III medical marijuana business only with each other. Dealing with anyone else “could be potential grounds for denial of a timely applicant’s application or revocation of a certificate of registration,” the guidance says.
Applicants are expected to “establish compliant supply chains no later than November 29, 2026.” Dispensaries and distributors may keep selling inventory they already hold, including products bought from businesses outside the system. The DEA said it does not plan to penalize registrants for sending small samples to state-licensed testing labs that lack a DEA registration.
What it means for adult-use states
The order does not cover adult-use cannabis, which remains in Schedule I while a separate rescheduling hearing continues, the DOJ said.
That leaves open how the DEA will treat businesses that serve both markets. Cannabis Business Times reported that the 23 adult-use states with operating markets account for nearly 2,800 timely applicants. The Minnesota Star Tribune reported that the DEA denied the application of In-Dispensary in Minneapolis, a store that serves both adult-use customers and medical patients, saying its setup failed to provide “robust” protections against diversion.
Ohio is in that group. Every Ohio dispensary, cultivator and processor holds a dual-use certificate of operation, according to the Division of Cannabis Control’s latest program update.
The rescheduling hearing
In the broader case to move marijuana to Schedule III, final responses on supplemental briefs about a Government Accountability Office report were due Nov. 5, The Marijuana Herald reported. Chief Administrative Law Judge Derek Julius can then move toward a recommendation, which will precede a final decision by DEA Administrator Terrance Cole. No deadline has been set.
Sources
- Cannabis Business Times: DEA Rules for Schedule III Medical Cannabis Registrants Pose Major Disruptions to State Programs (Nov. 2, 2026)
- The Marijuana Herald (Nov. 5, 2026)
- Ohio Division of Cannabis Control: Program Update, By the Numbers (Oct. 16, 2026)
Image: illustration generated with AI. It does not show the people, products or places in this story.



